Subhash Haldar

787 total citations
23 papers, 592 citations indexed

About

Subhash Haldar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Subhash Haldar has authored 23 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Subhash Haldar's work include Epigenetics and DNA Methylation (5 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Subhash Haldar is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Subhash Haldar collaborates with scholars based in United States, India and China. Subhash Haldar's co-authors include Neil A. Bhowmick, Rajeev Mishra, Manisha Tripathi, Frank Duong, Anisha Madhav, Zhenqiu Liu, Sandrine Billet, Diptiman Choudhury, Priyanka Agarwal and Krizia Rohena-Rivera and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Subhash Haldar

22 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subhash Haldar United States 12 274 200 146 124 116 23 592
Hana Lee South Korea 13 262 1.0× 89 0.4× 113 0.8× 99 0.8× 38 0.3× 31 519
Shaobo Yang China 12 189 0.7× 161 0.8× 90 0.6× 46 0.4× 169 1.5× 36 574
Alison Tyson-Capper United Kingdom 19 577 2.1× 171 0.9× 182 1.2× 58 0.5× 114 1.0× 40 948
Bobby Y. Reddy United States 13 237 0.9× 166 0.8× 74 0.5× 59 0.5× 169 1.5× 28 998
Lu Yin China 15 285 1.0× 247 1.2× 111 0.8× 79 0.6× 90 0.8× 60 674
Zhuo-la Liu China 5 247 0.9× 83 0.4× 63 0.4× 50 0.4× 89 0.8× 11 466
Kexing Fan China 10 215 0.8× 149 0.7× 60 0.4× 38 0.3× 223 1.9× 13 586
Lesa Begley United States 12 188 0.7× 236 1.2× 83 0.6× 190 1.5× 186 1.6× 16 617

Countries citing papers authored by Subhash Haldar

Since Specialization
Citations

This map shows the geographic impact of Subhash Haldar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhash Haldar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhash Haldar more than expected).

Fields of papers citing papers by Subhash Haldar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subhash Haldar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhash Haldar. The network helps show where Subhash Haldar may publish in the future.

Co-authorship network of co-authors of Subhash Haldar

This figure shows the co-authorship network connecting the top 25 collaborators of Subhash Haldar. A scholar is included among the top collaborators of Subhash Haldar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhash Haldar. Subhash Haldar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dey, Sananda, et al.. (2025). Surface Charge-Switchable Doxorubicin-Containing Polyurethane Prodrug Nanoparticles for Targeted Cancer Therapy. ACS Applied Nano Materials. 8(45). 21912–21921. 1 indexed citations
2.
Dey, Sananda, et al.. (2024). Parthenolide-Loaded Stimuli-Responsive Cross-Linked Nanocarrier for Targeting and Killing Triple-Negative Breast Cancer Cells. ACS Applied Nano Materials. 7(11). 12944–12957. 1 indexed citations
3.
Mishra, Rajeev, et al.. (2023). Prognostic value of circulating mitochondrial DNA in prostate cancer and underlying mechanism. Mitochondrion. 71. 40–49. 5 indexed citations
4.
Dey, Sananda, Tanushree Mondal, Subhash Haldar, et al.. (2022). Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection. Biomedicine & Pharmacotherapy. 156. 113801–113801. 37 indexed citations
5.
Mishra, Rajeev, et al.. (2022). TGF-β controls stromal telomere length through epigenetic modifications. 3 Biotech. 12(11). 290–290. 5 indexed citations
6.
Haldar, Subhash, Rajeev Mishra, Sandrine Billet, et al.. (2020). Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance. Proceedings of the National Academy of Sciences. 117(15). 8515–8523. 13 indexed citations
7.
Cheng, Ran, Sandrine Billet, Chuanxia Liu, et al.. (2019). Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells. Oncogene. 39(7). 1543–1556. 77 indexed citations
8.
Mishra, Rajeev, et al.. (2019). Epigenetic changes in fibroblasts drive cancer metabolism and differentiation. Endocrine Related Cancer. 26(12). R673–R688. 36 indexed citations
9.
Mishra, Rajeev, Subhash Haldar, Veronica R. Placencio, et al.. (2018). Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming. Journal of Clinical Investigation. 128(10). 4472–4484. 124 indexed citations
10.
Madhav, Anisha, Allen M. Andres, Frank Duong, et al.. (2018). Antagonizing CD105 enhances radiation sensitivity in prostate cancer. Oncogene. 37(32). 4385–4397. 23 indexed citations
11.
Kato, Manabu, Veronica Placencio-Hickok, Anisha Madhav, et al.. (2018). Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Oncogene. 38(5). 716–730. 71 indexed citations
13.
Haldar, Subhash, Rajeev Mishra, Manisha Tripathi, et al.. (2016). Histone deacetylase inhibitors mediate DNA damage repair in ameliorating hemorrhagic cystitis. Scientific Reports. 6(1). 39257–39257. 17 indexed citations
14.
Haldar, Subhash, Diptiman Choudhury, Rajeev Mishra, et al.. (2015). Inflammation and Pyroptosis Mediate Muscle Expansion in an Interleukin-1β (IL-1β)-dependent Manner. Journal of Biological Chemistry. 290(10). 6574–6583. 45 indexed citations
15.
Haldar, Subhash, et al.. (2014). Mechanisms of hemorrhagic cystitis.. PubMed. 2(3). 199–208. 57 indexed citations
16.
Haldar, Subhash, et al.. (2012). High copies of SUM1 enhance the stability of wild-type microtubules against adverse conditions in Saccharomyces cerevisiae. Biochemical and Biophysical Research Communications. 418(3). 525–530. 1 indexed citations
17.
18.
Haldar, Subhash, Shubho Das Gupta, Aparna Gomes, et al.. (2009). A high molecular weight protein Bengalin from the Indian black scorpion (Heterometrus bengalensis C.L. Koch) venom having antiosteoporosis activity in female albino rats. Toxicon. 55(2-3). 455–461. 9 indexed citations
19.
Gomes, Antony, Subhash Haldar, Biplab Giri, et al.. (2008). Experimental osteoporosis induced in female albino rats and its antagonism by Indian black scorpion (Heterometrus bengalensis C.L.Koch) venom. Toxicon. 53(1). 60–68. 16 indexed citations
20.
Haldar, Subhash, et al.. (1982). Studies on alkaline phosphatase, catalase and z-galactosidase in Vibrio el tor under normal and rifampicin resistant conditions.. PubMed. 31(3-4). 271–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026